BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ResMed Inc. (RMD) Patent Infringement Case Against BMC Advances: International Trade Commission Agrees to Investigate


8/21/2013 8:48:59 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO, Aug. 21, 2013 /PRNewswire/ -- The International Trade Commission has agreed to investigate Chinese medical device manufacturer BMC Medical Co., Ltd., and its distributors, Florida-based 3B Medical Inc. and 3B Products, L.L.C.. The Investigation was initiated at the request of ResMed (NYSE: RMD), a global innovator and pioneer in developing products for the treatment of sleep-disordered breathing and respiratory conditions. ResMed also filed suit in federal court against BMC in May, asserting patent infringement by:

  • The RESmart CPAP and RESmart Auto CPAP devices, and
  • The Willow nasal pillows patient interface and the iVolve nasal mask.

(Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

ResMed pursued a similar legal action earlier this year against Taiwanese manufacturer APEX Medical Corp. asserting patent infringement that resulted in APEX consenting to an order barring infringing products from the U.S. market.

"We're encouraged by the ITC's action to investigate this case against BMC," said ResMed Global General Counsel and Chief Administrative Officer David Pendarvis. "For more than two decades, ResMed has generated significant advances in innovative products for sleep-disordered breathing therapy We invest over $100 million in research and development each year to fuel these advances and other companies should not be allowed to infringe ResMed's intellectual property by using our technology."

About ResMed:
ResMed is a global leader in the development, manufacturing and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. The company is dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit www.resmed.com.

Contacts:


For News Media

For the Finance and Investor Community

Gretchen Griswold

Constance Bienfait

Director, Global Corporate Communications

Director, Investor Relations

O: 858-836-6789

O: 858-836-5971

news@resmed.com

constance.bienfait@resmed.com

SOURCE ResMed Inc.



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES